Bulletin of the Korean Chemical Society

Korean Chemical Society (대한화학회)
권호 표지
DOI QR코드

DOI QR Code

Evaluation of Sulfone Analogs of Cpd 5 as Cdc25 Inhibitors

  • Published : 2004.12.20
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Galaktionov, K.; Lee, A. K.; Eckstein, J.; Draetta, G.; Meckler,J.; Loda, M.; Beach, D. Science 1995, 269, 1575. https://doi.org/10.1126/science.7667636
  2. Galaktionov,K.; Chen, X.; Beach, D. Nature 1996, 382, 511. https://doi.org/10.1038/382511a0
  3. Kudo, Y.; Yasui, W.; Ue, T.; Yamamoto, S.; Yokozaki, H.;Nikai, H.; Tahara, E. Jpn. J. Cancer Res. 1997, 88, 9947.
  4. Wu,W. G.; Fan, Y. H.; Kemp, B. L.; Walsh, G.; Mao, L. Cancer Res.1998, 58, 4082.
  5. Cangi, M. G.; Cukor, B.; Soung, P.; Signoretti,S.; Moreira, G., Jr.; Ranashinge, M.; Cady, B.; Pagano, M.; Loda,M. J. Clin. Invest. 2000, 106, 753. https://doi.org/10.1172/JCI9174
  6. Broggini, M.; Buraggi, G.;Brenna, A.; Riva, L.; Codegoni, A. M.; Torri, V.; Lissoni, A. A.;Mangioni, C.; DIncalci, M. Anticancer Res. 2000, 20, 4835.
  7. Hernandez, S.; Bessa, X.; Hernandez, L.; Nadal, A.; Mallofre, C.;Muntane, J.; Castells, A.; Fernandez, P. L.; Cardesa, A.; Campo,E. Lab. Invest. 2001, 81, 465. https://doi.org/10.1038/labinvest.3780254
  8. Nishioka, K.; Doki, Y.; Shiozaki,H.; Yamamoto, H.; Tamura, S.; Yasuda, T.; Fujiwara, Y.; Yano,M.; Miyata, H.; Kishi, K.; Nakagawa, H.; Shamma, A.; Monden,M. Br. J. Cancer 2001, 85, 412. https://doi.org/10.1054/bjoc.2001.1934
  9. Ito, Y.; Yoshida, H.; Nakano,K.; Kobayashi, K.; Yokozawa, T.; Hirai, K.; Matsuzuka, F.;Matsuura, N.; Kakudo, K.; Kuma, K.; Miyauchi, A. Br. J. Cancer.2002, 86, 1909. https://doi.org/10.1038/sj.bjc.6600364
  10. Ngan, E. S.; Hashimoto, Y.; Ma, Z. Q.; Tsai,M. J.; Tsai, S. Y. Oncogene 2003, 22, 734. https://doi.org/10.1038/sj.onc.1206121
  11. Eckstein, J. W. Invest. New Drugs 2000, 18, 149. https://doi.org/10.1023/A:1006377913494
  12. Pesttell,K. E.; Ducruet, A. P.; Wipf, P.; Lazo, J. S. Oncogene 2002, 19,6607. https://doi.org/10.1038/sj.onc.1204084
  13. Lyon, M. A.; Ducruet, A. P.; Wipf, P.; Lazo, J. S. Nat.Rev. Drug Discov. 2002, 1, 961. https://doi.org/10.1038/nrd963
  14. Nishikawa, Y.; Carr, B. I.; Wang, M.; Kar, S.; Finn, F.; Dowd,P.; Zheng, Z. B.; Kerns, J.; Naganathan, S. J. Biol. Chem. 1995,270, 28304. https://doi.org/10.1074/jbc.270.47.28304
  15. Ham, S. W.; Park, H. J.; Lim, D. H. Bioorg. Chem.1997, 25, 33. https://doi.org/10.1006/bioo.1996.1052
  16. Ham, S. W.; Park, J.; Lee, S. J.; Kim, W.; Kang,K.; Choi, K. H. Bioorg. Med. Chem. Lett. 1998, 8, 2507. https://doi.org/10.1016/S0960-894X(98)00411-9
  17. Lazo,J. S.; Aslan, D. C.; Southwick, E. C.; Cooley, K. A.; Ducruet, A.P.; Joo, B.; Vogt, A.; Wipf, P. J. Med. Chem. 2001, 44, 4042. https://doi.org/10.1021/jm0102046
  18. Lazo, J. S.; Nemoto, K.; Pestell, K. E.; Cooley, K.; Southwick, E.C.; Mitchell, D. A.; Furey, W.; Gussio, R.; Zaharevitz, D. W.; Joo,B.; Wipf, P. Mol. Pharmacol. 2002, 61, 720. https://doi.org/10.1124/mol.61.4.720
  19. Sohn, J.; Kiburz,B.; Li, Z.; Deng, L.; Safi, A.; Pirrung, M. C.; Rudolph, J. J. Med.Chem. 2003, 46, 2580. https://doi.org/10.1021/jm0300835
  20. Tamura, K.; Southwick, E. C.; Kerns, J.; Rosi, K.; Carr, B. I.;Wilcox, C.; Lazo, J. S. Cancer Res. 2000, 60, 1317.
  21. Markovits, J.; Wang, Z.; Carr, B. I.; Sun, T. P.; Mintz, P.; Le Bret,M.; Wu, C. W.; Wu, F. Y. Life Sci. 2003, 72, 2769. https://doi.org/10.1016/S0024-3205(03)00188-7
  22. Biochemistry of Quinones; Morton, R. A., Ed.; Academic Press:New York, 1965.
  23. Wardman, P. Curr. Med. Chem. 2001, 8, 739. https://doi.org/10.2174/0929867013372959
  24. Potonay, T.; Adam, W.; Levai, A.; Koever, P.; Nemeth, M.; Peters,E.-M.; Peters, K. J. Org. Chem. 2001, 66, 2275. https://doi.org/10.1021/jo001469f
  25. Tamura, K.; Southwick, E. C.; Kerns, J.; Rosi, K.; Carr, B. I.;Wilcox, C.; Lazo, J. S. Cancer Res. 2000, 60, 1317.
  26. Vogt, A.; Adachi, T.; Ducruet, A. P.; Chesebrough, J.; Nemoto, K.;Carr, B. I.; Lazo, J. S. J. Biol. Chem. 2001, 276, 20544. https://doi.org/10.1074/jbc.M100078200

Cited by

  1. Evaluation of Sulfone Analogues of Cpd 5 as Cdc25 Inhibitors. vol.36, pp.22, 2005, https://doi.org/10.1002/chin.200522140
  2. Non-Quinone Sulfone Analog as a Cdc25 Inhibitor: Biological Evaluation and Structural Determinants of Cdc25A and Cdc25B Selectivity vol.29, pp.9, 2008, https://doi.org/10.5012/bkcs.2008.29.9.1659
  3. Bioactivities of simplified adociaquinone B and naphthoquinone derivatives against Cdc25B, MKP-1, and MKP-3 phosphatases vol.17, pp.6, 2004, https://doi.org/10.1016/j.bmc.2008.10.090